Last reviewed · How we verify

Aminophylline group

Tanta University · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Aminophylline group is a Small molecule drug developed by Tanta University. It is currently FDA-approved. Also known as: Theophylline.

Aminophylline is a medication used to treat various conditions, including acute exacerbation of chronic obstructive pulmonary disease and atrial fibrillation, as well as anesthesia and postdural puncture headache. It works as a phosphodiesterase 4 inhibitor, a type of protein modality that targets this enzyme.

At a glance

Generic nameAminophylline group
Also known asTheophylline
SponsorTanta University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Aminophylline group

What is Aminophylline group?

Aminophylline group is a Small molecule drug developed by Tanta University.

Who makes Aminophylline group?

Aminophylline group is developed and marketed by Tanta University (see full Tanta University pipeline at /company/tanta-university).

Is Aminophylline group also known as anything else?

Aminophylline group is also known as Theophylline.

What development phase is Aminophylline group in?

Aminophylline group is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing